Cite
MLA Citation
Robert Lupinacci et al.. “336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED).” Archives of disease in childhood, vol. 107, n.d., p. A204. http://access.bl.uk/ark:/81055/vdc_100161789560.0x000034